查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886061

全球免疫血液学仪器与试剂市场

Immunohematology Analyzers and Reagents
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球免疫血液分析仪和试剂市场预计2030年将达33亿美元

全球免疫血液分析仪及试剂市场规模在2024年估计为25亿美元，预计到2030年将达到33亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为4.7%。试剂是本报告分析的细分市场之一，预计在分析期结束时复合年增长率将达到4.2%，市场规模将达到23亿美元。分析仪细分市场预计在分析期间内复合年增长率将达到5.8%。

美国市场规模估计为6.788亿美元，而中国市场预计将以4.5%的复合年增长率成长。

预计2024年，美国免疫血液分析仪及试剂市场规模将达6.788亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5.19亿美元，2024年至2030年的复合年增长率（CAGR）为4.5%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率将分别达到4.3%和3.9%。在欧洲，德国的复合年增长率预计将达到约4.7%。

全球免疫血液分析仪和试剂市场—主要市场趋势和驱动因素概述

免疫血液分析仪和试剂如何确保输血安全？

免疫血液分析仪和试剂在输血医学领域至关重要，在确保输血的安全性和相容性方面发挥核心作用。这些先进的仪器和化学试剂用于检测血液样本中的重要标记物，例如血型、Rh因子以及某些可能在输血过程中引起不良反应的抗体。例如，血型鑑定对于确定捐血和受血者的相容性至关重要。免疫血液分析仪可自动完成此过程，检测并辨识红血球表面的抗原（例如A、B、RhD），帮助医疗团队准确判断捐血与受血者免疫系统的相容性。

除了血型鑑定外，免疫血液学试剂也用于识别可能因先前输血、怀孕或自体免疫疾病而产生的异常抗体。如果在输血前未能检测到这些抗体，则可能引起溶血反应，即身体攻击输注的红血球，导致危及生命的併发症。先进的免疫学技术，例如凝集试验、酵素免疫分析法(ELISA) 和微柱凝胶技术，使分析仪能够准确检测出即使是微量的此类抗体。免疫血液学分析仪和试剂提供快速、准确和自动化的检测，确保输血的安全性和成功率，最终在急诊和常规临床环境中挽救生命。

为什么免疫血液分析仪和试剂在疾病检测和血液管理中如此重要？

免疫血液分析仪和试剂的作用远不止于输血安全。它们对于诊断血液相关疾病以及治疗影响免疫系统和血液学的疾病也至关重要。其中一个最重要的应用是检测和治疗新生儿溶血病（HDN）。在HDN中，母体抗体会攻击胎儿的红血球，导致贫血和其他併发症。专业的免疫血液学试剂使医护人员能够检测抗D抗体和其他相关标记物，从而实现早期干预和治疗，包括透过注射Rh免疫球蛋白来预防HDN。

免疫血液学技术在自体免疫溶血性贫血的治疗中也扮演着至关重要的角色。自体免疫性溶血性贫血是一种自体免疫系统错误地破坏红血球的疾病。透过识别攻击患者血液的自身抗体，这些系统有助于确定合适的治疗方案，例如免疫抑制疗法和输注相容性血液。此外，在骨髓移植等复杂的医疗过程中，使用这些分析仪进行精确的血型匹配检测至关重要，以避免移植物抗宿主疾病（GVHD）的发生。在GVHD中，移植的细胞可能会攻击宿主的身体。

此外，免疫血液学试剂也用于后续观察接受长期治疗的患者，例如慢性贫血患者或接受化疗的癌症患者。常规血液检测对于评估免疫功能和整体血液健康至关重要。免疫血液学分析仪的自动化功能可确保高通量和准确的结果，这对于疾病的持续管理至关重要。随着免疫和血液疾病的日益复杂，这些系统已成为临床医生不可或缺的工具，有助于有效诊断、监测和管理各种血液疾病。

免疫血液分析仪如何推动检查室创新？

免疫血液分析仪处于检查室自动化的前沿，透过简化工作流程和提高检测准确性，彻底改变了血库和临床检查室的运作方式。该领域的一项重大进展是将自动化和机器人技术整合到免疫血液系统中，从而实现了血液样本的高通量处理。现代分析仪每天能够处理数百个检体，且只需极少的人工干预，从而降低了人为错误的风险，并确保了检测流程的标准化。这对于大型医院和血库尤其重要，因为这些机构对血液製品的需求持续不断，快速可靠的检测结果对患者照护至关重要。

将先进的软体和数据管理工具整合到免疫血液分析仪中，大大提高了检查室效率。这些系统现在可以与医院资讯系统 (HIS) 和实验室资讯管理系统 (LIMS) 集成，从而实现不同部门之间的无缝资讯共用。这种连接性使得检测结果能够即时共用给医护人员，并加快临床决策过程，尤其是在分秒必争的紧急情况下。此外，人工智慧 (AI) 和机器学习演算法的不断发展，透过学习大量资料集，进一步提高了分析仪的准确性，增强了其预测和检测可能被忽略的罕见抗体的能力。

另一个大趋势是免疫血液学系统的微型化，使得就地检验在更多环境下成为现实。采用微流体技术的携带式分析仪的问世，即使在偏远和资源匮乏的地区，也能实现快速的现场血液检测。这些进步显着提高了免疫血液学检测的可及性和速度，确保在需要时随时随地提供高品质、可靠的诊断。随着技术的不断发展，免疫血液学分析仪仍将是实验室医学转型的重要组成部分，协助建构更有效率、更精准、更快速反应的医疗保健系统。

哪些因素正在推动免疫血液分析仪和试剂市场的成长？

免疫血液分析仪和试剂市场的成长受多种关键因素驱动，这些因素共同推动了对这些技术的需求不断增长。其中一个关键驱动因素是全球输血需求的日益增长。随着人口老化、癌症和贫血等慢性疾病的流行以及复杂手术的增加，对安全且相容的血液製品的需求持续增长。免疫血液分析仪透过提供快速且准确的血型鑑定和抗体筛检来确保输血安全，从而促进了其在全球医院、血库和诊所的应用。

另一个关键因素是自动化在临床检查室中日益增长的重要性。随着检查室面临越来越大的压力，需要在处理更大样本量的同时提供更快、更准确的结果，现代免疫血液分析仪的自动化功能变得至关重要。这些系统不仅减少了人工劳动，最大限度地减少了人为错误，还能实现连续、高通量的检测，以满足现代医疗环境的需求。在医疗基础设施完善的已开发国家，这种趋势尤其明显，因为大规模血液检测已成为常规需求。

免疫血液学试剂的技术进步也推动了市场成长。更具特异性、灵敏度和稳定性的试剂的开发提高了血液检测的性能，增强了对罕见抗体和抗原的检测准确性。这些创新拓展了免疫血液学检测的效用，使其不仅适用于常规检测，也适用于自体免疫疾病和罕见血型等复杂病例。此外，个人化医疗的兴起和对精准诊断日益增长的关注也推动了对先进免疫血液学技术的需求。这些技术能够提供製定个人化治疗方案所需的详细分子资讯。

最后，监管支持的加强和公众对安全输血重要性的认识提高也是市场扩张的推动因素。各国政府和医疗机构正在实施严格的指导方针和措施来提高输血安全性，这促使免疫血液分析仪和试剂的使用量不断增长。随着这一趋势的持续，在日益复杂的医疗环境中，对自动化和高精度血液检测的需求不断增加，预计免疫血液学市场将显着增长。

部分：

依产品（试剂、分析设备）、技术（聚合酵素链锁反应、凝胶卡、生物晶片、红血球磁化、微孔盘）、应用（医院、诊断和参考检查室、血库、学术和研究机构）分类

受访公司范例

  • Immucor, Inc.
  • Merck &Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用典型的 LLM 或产业专用的SLM 方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP12535

Global Immunohematology Analyzers and Reagents Market to Reach US$3.3 Billion by 2030

The global market for Immunohematology Analyzers and Reagents estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$678.8 Million While China is Forecast to Grow at 4.5% CAGR

The Immunohematology Analyzers and Reagents market in the U.S. is estimated at US$678.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$519.0 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Immunohematology Analyzers and Reagents Market - Key Trends and Drivers Summarized

How Do Immunohematology Analyzers and Reagents Work to Ensure Safe Blood Transfusions?

Immunohematology analyzers and reagents are vital in the field of transfusion medicine, playing a central role in ensuring the safety and compatibility of blood transfusions. These sophisticated devices and chemicals are used to test blood samples for key markers, such as blood type, Rh factor, and the presence of specific antibodies that could cause adverse reactions during transfusions. Blood typing, for example, is crucial in matching donors and recipients. Immunohematology analyzers automate this process, detecting and identifying antigens (like A, B, and RhD) on the surface of red blood cells, helping medical teams to accurately determine the compatibility between donated blood and the recipient's immune system.

In addition to blood typing, immunohematology reagents are used to identify irregular antibodies that can form due to previous transfusions, pregnancy, or autoimmune conditions. These antibodies can cause hemolytic reactions if not detected before a transfusion, where the body attacks transfused red blood cells, potentially leading to life-threatening complications. Through advanced immunological techniques like agglutination, enzyme-linked immunosorbent assays (ELISA), and microcolumn gel technology, analyzers can precisely identify even low levels of these antibodies. By providing fast, accurate, and automated testing, immunohematology analyzers and reagents ensure the safety and success of blood transfusions, ultimately saving lives in both emergency and routine clinical settings.

Why Are Immunohematology Analyzers and Reagents Crucial in Disease Detection and Blood Management?

Immunohematology analyzers and reagents go far beyond transfusion safety-they are also essential in diagnosing blood-related disorders and managing diseases that affect the immune and hematologic systems. One of the most critical applications is in the detection and management of hemolytic diseases of the newborn (HDN), where a mother's antibodies attack the fetus’s red blood cells, leading to anemia and other complications. Through the use of specialized immunohematology reagents, healthcare professionals can detect anti-D antibodies and other relevant markers, allowing for early intervention and treatment, such as administering Rh immunoglobulin to prevent HDN.

Immunohematology technologies also play a pivotal role in managing autoimmune hemolytic anemia, a condition where the immune system mistakenly destroys red blood cells. By identifying autoantibodies that are attacking the patient’s blood, these systems help guide appropriate treatment, such as immunosuppressive therapy or the administration of compatible blood transfusions. Furthermore, in complex medical procedures like bone marrow transplants, accurate blood matching facilitated by these analyzers is crucial to avoid graft-versus-host disease, where the transplanted cells may attack the host’s body.

Additionally, immunohematology reagents are used to monitor patients undergoing long-term therapies, such as those with chronic anemia or cancer patients receiving chemotherapy, where regular blood testing is necessary to assess immune function and overall blood health. The automation provided by immunohematology analyzers ensures high-throughput, precise results that are critical for ongoing disease management. As the complexity of immunological and hematological conditions continues to grow, these systems provide indispensable tools for clinicians, helping to diagnose, monitor, and manage a wide array of blood disorders effectively.

How Are Immunohematology Analyzers Driving Technological Innovation in Laboratories?

Immunohematology analyzers are at the forefront of laboratory automation, revolutionizing the way blood banks and clinical labs operate by streamlining workflows and increasing testing accuracy. One of the key advancements in this field is the integration of automation and robotics within immunohematology systems, allowing for high-throughput processing of blood samples. Modern analyzers can process hundreds of samples per day with minimal human intervention, reducing the risk of human error and ensuring standardized testing procedures. This is especially important in large hospitals and blood banks where the demand for blood products is constant, and rapid, reliable results are critical for patient care.

The incorporation of advanced software and data management tools into immunohematology analyzers has also transformed laboratory efficiency. These systems are now capable of integrating with hospital information systems (HIS) and laboratory information management systems (LIMS), allowing for seamless communication between different departments. This connectivity enables real-time sharing of test results with healthcare providers, speeding up clinical decision-making processes, particularly in emergencies where time is of the essence. Additionally, artificial intelligence and machine learning algorithms are being developed to further enhance the precision of these analyzers, by learning from vast datasets to predict and detect rare antibodies that might otherwise go unnoticed.

Another major trend is the miniaturization of immunohematology systems, making point-of-care testing a reality in more settings. Portable analyzers equipped with microfluidic technologies are being introduced, enabling fast, on-site blood testing even in remote or resource-limited environments. These advances are drastically improving the accessibility and speed of immunohematology testing, ensuring that high-quality, reliable diagnostics are available where and when they are needed. As technology continues to evolve, immunohematology analyzers will remain integral to the transformation of laboratory medicine, leading to more efficient, accurate, and responsive healthcare systems.

What’s Driving the Growth in the Immunohematology Analyzer and Reagent Market?

The growth in the immunohematology analyzer and reagent market is driven by several critical factors, each contributing to the increasing demand for these technologies. One of the primary drivers is the rising need for blood transfusions globally. With an aging population, the prevalence of chronic diseases, such as cancer and anemia, and an increasing number of complex surgeries, the demand for safe and compatible blood products continues to grow. Immunohematology analyzers ensure that blood transfusions are safe by providing rapid and accurate blood typing and antibody screening, which has fueled their adoption across hospitals, blood banks, and clinics worldwide.

Another significant factor is the growing emphasis on automation in clinical laboratories. As labs face increasing pressure to deliver faster, more accurate results while managing higher volumes of tests, the automation capabilities of modern immunohematology analyzers are becoming indispensable. These systems not only reduce manual labor and minimize human error but also allow for continuous, high-throughput testing that meets the demands of modern healthcare environments. This trend is particularly evident in developed countries with well-established healthcare infrastructures, where large-scale blood testing is a daily requirement.

Technological advancements in immunohematology reagents are also contributing to market growth. The development of more specific, sensitive, and stable reagents has enhanced the performance of blood tests, leading to improved detection of rare antibodies and antigens. These innovations have expanded the utility of immunohematology assays in both routine testing and complex cases, such as those involving autoimmune disorders or rare blood types. Furthermore, the rise of personalized medicine and the increasing focus on precision diagnostics are driving demand for advanced immunohematology technologies, which offer the detailed molecular insights needed for tailored treatment plans.

Finally, regulatory support and increasing public awareness about the importance of safe blood transfusions have also played a role in market expansion. Governments and healthcare organizations are implementing stringent guidelines and initiatives to improve transfusion safety, which has led to higher adoption rates of immunohematology analyzers and reagents. As these trends continue, the immunohematology market is poised for substantial growth, driven by the rising need for automated, high-precision blood testing in an increasingly complex healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Immunohematology Analyzers and Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents, Analyzers); Technology (Polymerase Chain Reaction, Gel Cards, Biochips, Erythrocyte-Magnetized, Microplates); End-Use (Hospitals, Diagnostic & Reference Laboratories, Blood Banks, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • Immucor, Inc.
  • Merck & Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Immunohematology Analyzers and Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Transfusions Drives Growth in Immunohematology Analyzers and Reagents Market
    • Expansion of Blood Bank Services Spurs Adoption of Immunohematology Analyzers
    • Increasing Focus on Fully Automated and High-throughput Immunohematology Analyzers Fuels Market Demand
    • Growth in Use of Immunohematology in Crossmatching and Compatibility Testing Expands Market Opportunities
    • Growth in Demand for Immunohematology Analyzers in Hospital Laboratories Fuels Market Expansion
    • Increasing Focus on Immunohematology for Rare Blood Group Detection Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Immunohematology Analyzers and Reagents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gel cards by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Erythrocyte-Magnetized by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic & Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION